DE69840495D1 - Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben - Google Patents
Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselbenInfo
- Publication number
- DE69840495D1 DE69840495D1 DE69840495T DE69840495T DE69840495D1 DE 69840495 D1 DE69840495 D1 DE 69840495D1 DE 69840495 T DE69840495 T DE 69840495T DE 69840495 T DE69840495 T DE 69840495T DE 69840495 D1 DE69840495 D1 DE 69840495D1
- Authority
- DE
- Germany
- Prior art keywords
- deletes
- production
- pharmaceutical form
- dispersion properties
- rapid dispersion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y80/00—Products made by additive manufacturing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3888397P | 1997-02-20 | 1997-02-20 | |
US3828497P | 1997-02-20 | 1997-02-20 | |
PCT/US1998/003256 WO1998036738A1 (en) | 1997-02-20 | 1998-02-20 | Dosage form exhibiting rapid disperse properties, methods of use and process for the manufacture of same |
Publications (1)
Publication Number | Publication Date |
---|---|
DE69840495D1 true DE69840495D1 (de) | 2009-03-12 |
Family
ID=26715043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69840495T Expired - Lifetime DE69840495D1 (de) | 1997-02-20 | 1998-02-20 | Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben |
Country Status (9)
Country | Link |
---|---|
US (3) | US6471992B1 (de) |
EP (1) | EP0973507B1 (de) |
JP (3) | JP4563516B2 (de) |
AT (1) | ATE421318T1 (de) |
AU (1) | AU736912B2 (de) |
CA (1) | CA2281473C (de) |
DE (1) | DE69840495D1 (de) |
ES (1) | ES2318869T3 (de) |
WO (1) | WO1998036738A1 (de) |
Families Citing this family (75)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE421318T1 (de) * | 1997-02-20 | 2009-02-15 | Massachusetts Inst Technology | Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben |
KR101032289B1 (ko) * | 1998-05-18 | 2011-05-06 | 다케다 야쿠힌 고교 가부시키가이샤 | 미세과립 |
US6284270B1 (en) * | 1999-08-04 | 2001-09-04 | Drugtech Corporation | Means for creating a mass having structural integrity |
WO2002003966A2 (en) * | 2000-07-10 | 2002-01-17 | Therics, Inc. | Method and materials for controlling migration of binder liquid in a powder |
IL159287A0 (en) * | 2001-06-28 | 2004-06-01 | Ucb Farchim Sa | Tablet comprising cetirizine and pseudoephedrine |
CA2448558A1 (en) * | 2001-07-10 | 2003-01-23 | Teva Pharmaceutical Industries, Ltd. | Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery |
US20030099708A1 (en) * | 2001-10-29 | 2003-05-29 | Therics, Inc | Printing or dispensing a suspension such as three-dimensional printing of dosage forms |
WO2003037607A1 (en) * | 2001-10-29 | 2003-05-08 | Therics, Inc. | A system and method for uniaxial compression of an article, such as a three-dimensionally printed dosage form |
AU2003232078A1 (en) * | 2002-05-06 | 2003-11-17 | Massachusetts Institute Of Technology | Diffusion-controlled dosage form and method of fabrication including three dimensional printing |
MXPA05005528A (es) * | 2002-11-26 | 2006-04-05 | Alk Abello As | Producto farmaceutico de alergeno. |
WO2006034414A2 (en) | 2004-09-21 | 2006-03-30 | Hypnion, Inc. | Loxapine analogs and methods of use thereof |
US7829000B2 (en) * | 2005-02-25 | 2010-11-09 | Hewlett-Packard Development Company, L.P. | Core-shell solid freeform fabrication |
US8187659B2 (en) | 2006-05-02 | 2012-05-29 | Jerry Robertson Real Estate Llc | Solid medicament dosage form consumption aid |
DK2041071T3 (da) | 2006-06-29 | 2014-09-01 | Kinex Pharmaceuticals Llc | Biarylsammensætninger og fremgangsmåder til modulering af en kinasekaskade |
CA2703615C (en) | 2007-10-20 | 2017-09-19 | Kinex Pharmaceuticals, Llc | Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof |
AU2010313785C1 (en) | 2009-10-30 | 2019-04-11 | Ix Biopharma Ltd | Fast dissolving solid dosage form |
EP2555751B8 (de) * | 2010-04-03 | 2018-02-14 | Praful Doshi | Verfahren zum beschichtigen von einer kontaktlinse |
WO2012056319A1 (en) | 2010-10-27 | 2012-05-03 | Dynamix Pharmaceuticals Ltd. | Sulfonamides for the modulation of pkm2 |
EP2655334B1 (de) | 2010-12-22 | 2018-10-03 | Eutropics Pharmaceuticals, Inc. | Zusammensetzungen und verfahren zur behandlung von erkrankungen |
US8722636B2 (en) | 2011-01-31 | 2014-05-13 | New Market Pharmaceuticals, LLC | Animal treatments |
EP2684167B1 (de) | 2011-03-08 | 2020-09-09 | Eutropics Pharmaceuticals, Inc. | Zusammensetzungen und verfahren zur behandlung von erkrankungen |
ITMI20110791A1 (it) | 2011-05-09 | 2012-11-10 | Probiotical Spa | Ceppi di batteri in grado di metabolizzare gli ossalati. |
ITMI20110793A1 (it) | 2011-05-09 | 2012-11-10 | Probiotical Spa | Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati. |
ITMI20110792A1 (it) | 2011-05-09 | 2012-11-10 | Probiotical Spa | Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia. |
WO2012160447A1 (en) | 2011-05-25 | 2012-11-29 | Dynamix Pharmaceuticals Ltd. | 3, 5 -diphenyl- substituted pyrazolines for the treatment of cancer, proliferative, inflammatory or autoimmune diseases |
AU2012270029B2 (en) | 2011-06-07 | 2017-08-10 | Clevexel Pharma | Compositions and methods for modulating a kinase |
ITMI20111718A1 (it) | 2011-09-23 | 2013-03-24 | Probiotical Spa | Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali. |
US9245061B2 (en) * | 2012-04-25 | 2016-01-26 | Shapeways, Inc. | Weight-based identification of three dimensional printed parts |
AU2012379005B2 (en) | 2012-05-02 | 2017-12-21 | Newmarket Pharmaceuticals Llc | Pharmaceutical compositions for direct systemic introduction |
IN2014DN11205A (de) | 2012-06-20 | 2015-10-02 | Eutropics Pharmaceuticals Inc | |
US9926273B2 (en) | 2012-08-30 | 2018-03-27 | Athenex, Inc. | Composition and methods for modulating a kinase cascade |
US9545376B2 (en) | 2013-01-23 | 2017-01-17 | Arx, Llc | Production of unit dose constructs |
US9339489B2 (en) | 2013-03-15 | 2016-05-17 | Aprecia Pharmaceuticals Company | Rapid disperse dosage form containing levetiracetam |
JP6170234B2 (ja) * | 2013-03-15 | 2017-07-26 | アプレシア・ファーマスーティカルズ・カンパニー | レベチラセタムを含む急速に分散する剤形 |
JP6463333B2 (ja) | 2013-03-15 | 2019-01-30 | アプレシア・ファーマスーティカルズ・カンパニー | オキシカルバゼピンの急速分散性の剤形 |
ES2761407T3 (es) * | 2013-03-15 | 2020-05-19 | Aprecia Pharmaceuticals LLC | Forma de dosificación rápidamente dispersable de topiramato |
WO2014176389A1 (en) | 2013-04-24 | 2014-10-30 | Temple University - Of The Commonwealth System Of Higher Education | Solid dosage form containing arabinogalactan |
ITMI20130793A1 (it) | 2013-05-14 | 2014-11-15 | Probiotical Spa | Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti. |
CN105579161A (zh) | 2013-08-16 | 2016-05-11 | 艾克斯温有限责任公司 | 三维打印的金属铸造模具和其制造方法 |
EP3057729A4 (de) | 2013-10-17 | 2017-10-18 | The Exone Company | Isostatische heisspressbehälter mit 3d-druck und verfahren zur herstellung davon |
WO2015100084A1 (en) | 2013-12-23 | 2015-07-02 | The Exone Company | Method of three-dimensional printing using a multi-component build powder |
WO2015100085A2 (en) * | 2013-12-23 | 2015-07-02 | The Exone Company | Methods and systems for three-dimensional printing utilizing a jetted-particle binder fluid |
ES2745763T3 (es) | 2013-12-23 | 2020-03-03 | The Exone Co | Métodos y sistemas para la impresión en tres dimensiones utilizando múltiples fluidos aglutinantes |
US20160184230A1 (en) * | 2014-04-30 | 2016-06-30 | Aron H. Blaesi | Melt-processed polymeric cellular dosage form |
US20170120329A1 (en) | 2014-05-29 | 2017-05-04 | The Exone Company | Process for Making Nickel-Based Superalloy Articles by Three-Dimensional Printing |
WO2016011098A2 (en) | 2014-07-17 | 2016-01-21 | The Exone Company | Methods and apparatuses for curing three-dimensional printed articles |
AU2015350148B2 (en) | 2014-11-21 | 2020-11-26 | Biohaven Pharmaceutical Holding Company Ltd. | Sublingual formulation of riluzole |
WO2016089618A1 (en) | 2014-12-03 | 2016-06-09 | The Exone Company | Process for making densified carbon articles by three dimensional printing |
AU2016272089B2 (en) | 2015-06-03 | 2021-02-18 | Triastek, Inc. | Dosage forms and use thereof |
EP3108874A1 (de) * | 2015-06-26 | 2016-12-28 | TRB Chemedica AG | Pharmazeutische zubereitung zur anwendung am auge |
US11129798B2 (en) * | 2016-08-19 | 2021-09-28 | Aron H. Blaesi | Fibrous dosage form |
CA3018012A1 (en) * | 2016-03-18 | 2017-09-21 | Grunenthal Gmbh | Combination of drugs having different potency |
WO2017175792A1 (ja) * | 2016-04-06 | 2017-10-12 | アステラス製薬株式会社 | 速溶出性三次元造形物、速溶出性三次元造形物用フィラメント及び速溶出性三次元造形物用材料 |
JP6559912B2 (ja) | 2016-05-05 | 2019-08-14 | トリアステック インコーポレイテッド | 放出制御剤形 |
AU2017266951B2 (en) | 2016-05-20 | 2021-05-27 | Biohaven Pharmaceutical Holding Company Ltd. | Use of Glutamate modulating agents with Immunotherapies to treat cancer |
ES2914526T3 (es) | 2016-08-12 | 2022-06-13 | Athenex Inc | Composiciones de biarilo y métodos para modular una cascada de cinasa |
US11040491B2 (en) | 2016-10-19 | 2021-06-22 | Shapeways, Inc. | Systems and methods for identifying three-dimensional printed objects |
CA3045043A1 (en) | 2016-12-31 | 2018-07-05 | Bioxcel Therapeutics, Inc. | Use of sublingual dexmedetomidine for the treatment of agitation |
US11602502B2 (en) | 2017-02-24 | 2023-03-14 | Hewlett-Packard Development Company, L.P. | Three-dimensional (3D) printing a pharmaceutical tablet |
CA3053254C (en) | 2017-03-08 | 2024-02-20 | Cinrx Pharma, Llc | Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol |
JP7358340B2 (ja) | 2017-05-26 | 2023-10-10 | インフィニット・マテリアル・ソリューションズ,エルエルシー | 水溶性ポリマー組成物 |
JP7352542B2 (ja) | 2017-11-12 | 2023-09-28 | バイオヘイブン・セラピューティクス・リミテッド | 運動失調を処置するためのリルゾールプロドラッグの使用 |
CN108066302B (zh) * | 2017-12-28 | 2020-09-11 | 无限极(中国)有限公司 | 一种快速分散固体制剂的制备方法及制备的快速分散固体制剂 |
US10350822B1 (en) | 2018-01-09 | 2019-07-16 | Triastek Inc. | Dosage forms with desired release profiles and methods of designing and making thereof |
CN116270513A (zh) | 2018-01-09 | 2023-06-23 | 南京三迭纪医药科技有限公司 | 一种包含固定剂量adhd非兴奋剂和adhd兴奋剂的复方口服药物剂型 |
DE102018107585B3 (de) * | 2018-03-29 | 2019-03-28 | Universität Rostock | Vorrichtung zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen mit Wirkstoffdepots, sowie Verfahren zur Herstellung von 3D-gedruckten Wirkstofffreisetzungssystemen |
JP2021529756A (ja) | 2018-06-27 | 2021-11-04 | バイオエクセル セラピューティクス,インコーポレイテッド | デクスメデトミジンを含むフィルム製剤、及びその作製方法 |
US11278501B2 (en) | 2018-10-15 | 2022-03-22 | Aprecia Pharmaceuticals LLC | Method and system for forming a dosage form within a packaging |
EP3883546A1 (de) | 2018-11-21 | 2021-09-29 | Rosemont Pharmaceuticals Ltd | Orale topiramat-suspensionsformulierungen mit verlängerter lagerstabilität und verbesserter bioverfügbarkeit |
JP7287032B2 (ja) | 2019-03-20 | 2023-06-06 | 株式会社リコー | シート、シート積層体、医薬品、シートの製造方法、及びシート積層体の製造方法 |
EP3972567A1 (de) * | 2019-05-21 | 2022-03-30 | DFE Pharma GmbH & Co. KG | Dreidimensionales laktosepulverbettdrucken |
AU2020316013A1 (en) | 2019-07-19 | 2022-02-17 | Arx, Llc | Non-sedating dexmedetomidine treatment regimens |
TWI734309B (zh) * | 2019-12-19 | 2021-07-21 | 水星生醫股份有限公司 | 滲透性噴塗製作藥錠裝置 |
JP2023533478A (ja) | 2020-06-26 | 2023-08-03 | アプレシア・ファーマスーティカルズ・エルエルシー | 内部空洞を有する迅速口内分散可能な錠剤 |
KR20230098628A (ko) | 2020-10-30 | 2023-07-04 | 트리아스텍 인코포레이티드 | 위장관 약학적 제형 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4642903A (en) | 1985-03-26 | 1987-02-17 | R. P. Scherer Corporation | Freeze-dried foam dosage form |
US4855326A (en) | 1987-04-20 | 1989-08-08 | Fuisz Pharmaceutical Ltd. | Rapidly dissoluble medicinal dosage unit and method of manufacture |
US4990535A (en) * | 1989-05-03 | 1991-02-05 | Schering Corporation | Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine |
FR2647343B1 (fr) * | 1989-05-24 | 1994-05-06 | Rhone Poulenc Sante | Nouvelle forme pharmaceutique poreuse et sa preparation |
US5206025A (en) | 1989-05-24 | 1993-04-27 | Rhone-Poulenc Sante | Porous pharmaceutical form and its preparation |
EP0418596A3 (en) * | 1989-09-21 | 1991-10-23 | American Cyanamid Company | Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form |
US5204055A (en) | 1989-12-08 | 1993-04-20 | Massachusetts Institute Of Technology | Three-dimensional printing techniques |
US5578322A (en) | 1990-11-30 | 1996-11-26 | Yamanouchi Pharmaceutical Co., Ltd. | Quick release coated preparation |
DK0500225T3 (da) | 1991-01-31 | 1996-02-05 | Texas Instruments Inc | System, fremgangsmåde og proces til computerstyret fremstilling af tredimensionale genstande udfra computerdata |
CA2124686C (en) * | 1991-12-20 | 1998-06-16 | Julian B. Lo | Porous shaped delivery devices and method of producing thereof |
JP2521612B2 (ja) * | 1992-05-20 | 1996-08-07 | ウエイ・ミン・フアーマシユーテイカル・マニユフアクチヤリング・カンパニー・リミテツド | 直接錠剤形成助剤 |
US5518730A (en) | 1992-06-03 | 1996-05-21 | Fuisz Technologies Ltd. | Biodegradable controlled release flash flow melt-spun delivery system |
US5380473A (en) | 1992-10-23 | 1995-01-10 | Fuisz Technologies Ltd. | Process for making shearform matrix |
DE4303846A1 (de) * | 1993-02-10 | 1994-08-11 | Merck Patent Gmbh | Verfahren zur Herstellung einer S-Ibuprofen enthaltenden Tablette |
WO1995001782A2 (en) * | 1993-07-09 | 1995-01-19 | R.P. Scherer Corporation | Method for making freeze dried drug dosage forms |
US6176874B1 (en) | 1993-10-18 | 2001-01-23 | Masschusetts Institute Of Technology | Vascularized tissue regeneration matrices formed by solid free form fabrication techniques |
US5490962A (en) | 1993-10-18 | 1996-02-13 | Massachusetts Institute Of Technology | Preparation of medical devices by solid free-form fabrication methods |
US6280771B1 (en) | 1997-02-20 | 2001-08-28 | Therics, Inc. | Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof |
US5503785A (en) | 1994-06-02 | 1996-04-02 | Stratasys, Inc. | Process of support removal for fused deposition modeling |
US5633021A (en) | 1994-10-19 | 1997-05-27 | Bpm Technology, Inc. | Apparatus for making a three-dimensional article |
US5607697A (en) | 1995-06-07 | 1997-03-04 | Cima Labs, Incorporated | Taste masking microparticles for oral dosage forms |
US5560927A (en) * | 1995-07-28 | 1996-10-01 | Isp Investments Inc. | Co-processing method for making a free-flowing compressible powder and tablet therefrom |
US5653925A (en) * | 1995-09-26 | 1997-08-05 | Stratasys, Inc. | Method for controlled porosity three-dimensional modeling |
ATE421318T1 (de) * | 1997-02-20 | 2009-02-15 | Massachusetts Inst Technology | Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben |
DE19940944B4 (de) * | 1999-08-31 | 2006-10-12 | Grünenthal GmbH | Retardierte, orale, pharmazeutische Darreichungsformen |
-
1998
- 1998-02-20 AT AT98907531T patent/ATE421318T1/de not_active IP Right Cessation
- 1998-02-20 DE DE69840495T patent/DE69840495D1/de not_active Expired - Lifetime
- 1998-02-20 WO PCT/US1998/003256 patent/WO1998036738A1/en active Search and Examination
- 1998-02-20 CA CA002281473A patent/CA2281473C/en not_active Expired - Lifetime
- 1998-02-20 EP EP98907531A patent/EP0973507B1/de not_active Expired - Lifetime
- 1998-02-20 AU AU63314/98A patent/AU736912B2/en not_active Ceased
- 1998-02-20 JP JP53687898A patent/JP4563516B2/ja not_active Expired - Lifetime
- 1998-02-20 ES ES98907531T patent/ES2318869T3/es not_active Expired - Lifetime
- 1998-02-20 US US09/027,183 patent/US6471992B1/en not_active Expired - Lifetime
-
2002
- 2002-07-19 US US10/200,029 patent/US9463160B2/en not_active Expired - Fee Related
-
2009
- 2009-05-11 JP JP2009114753A patent/JP5091910B2/ja not_active Expired - Lifetime
- 2009-11-09 JP JP2009256374A patent/JP2010120938A/ja not_active Withdrawn
-
2012
- 2012-02-09 US US13/369,473 patent/US9114072B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2281473C (en) | 2007-01-16 |
US6471992B1 (en) | 2002-10-29 |
EP0973507B1 (de) | 2009-01-21 |
ATE421318T1 (de) | 2009-02-15 |
US9463160B2 (en) | 2016-10-11 |
ES2318869T3 (es) | 2009-05-01 |
JP5091910B2 (ja) | 2012-12-05 |
CA2281473A1 (en) | 1998-08-27 |
JP2010120938A (ja) | 2010-06-03 |
US20120207929A1 (en) | 2012-08-16 |
US20030133975A1 (en) | 2003-07-17 |
JP4563516B2 (ja) | 2010-10-13 |
JP2009215305A (ja) | 2009-09-24 |
US9114072B2 (en) | 2015-08-25 |
AU736912B2 (en) | 2001-08-02 |
JP2001512488A (ja) | 2001-08-21 |
AU6331498A (en) | 1998-09-09 |
WO1998036738A1 (en) | 1998-08-27 |
EP0973507A1 (de) | 2000-01-26 |
EP0973507A4 (de) | 2006-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69840495D1 (de) | Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben | |
DE69704426T2 (de) | Verfahren zur herstellung von medizinischem kaugummi mit einem guten geschmack, enthaltend eine einschlussverbindung | |
DE10224607B4 (de) | Filmförmige, zerfallsfähige Zubereitungen zur Wirkstofffreisetzung und Verfahren zu deren Herstellung | |
ATE260651T1 (de) | Pharmazeutische ciclosporin-formulierung mit verbesserten biopharmazeutischen eigenschaften, erhöhter physikalischer qualität & stabilität sowie verfahren zur herstellung | |
DE69614685T2 (de) | Mittel zur verzögerten freisetzung von menschlichem wachstumshormon | |
DE69919863T8 (de) | Stabilgelmischung in form einer mischung eines öligen gels und eines wässrigen gels | |
IS4083A (is) | Samsetning lyfjaefna, aðferð til framleiðslu hennar, og notkunar sem lyfja | |
IL76256A (en) | Controlled-release medical preparations and method for their preparation | |
DE3850823T3 (de) | System zur Freisetzung von Medikamenten und dessen Herstellungsmethode. | |
HUT55220A (en) | Process for producing pharmaceutical composition suitable for systemic administration through the skin and comprising deprenyl as active ingredient | |
ATE375729T1 (de) | Verfahren zur herstellung eines pharmazeutischen kaugummis | |
GR3018970T3 (en) | Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions. | |
ATE149826T1 (de) | Verfahren zur herstellung von festen pharmazeutischen retardformen | |
ATE249819T1 (de) | Präparate zur äusserlichen anwendung zur behandlung von dermatosen | |
DE60211769D1 (de) | Verfahren zur Herstellung von Arzneistoffgranulatkörnern, die Arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische Zubereitungen | |
DE69527711D1 (de) | Verfahren und apparat zur herstellung von schnelllöslichen dosierungseinheiten und daraus erhältliches produkt | |
ATE282406T1 (de) | Arzneimittel und verfahren zur behandlung von intrazellulären infektionen | |
DE69001573D1 (de) | Zusammensetzungen zur herstellung von in dosisformen aktiven vitaminen d3 sowie verfahren zur herstellung stabiler, in dosisformen aktiver vitamine d3 unter deren verwendung. | |
UA60352C2 (uk) | Синтетичні полісахариди та фармацевтична композиція, що їх містить | |
Reiz et al. | EMLA--a eutectic mixture of local anaesthetics for topical anaesthesia | |
ATA379182A (de) | Verfahren zur herstellung von presslingen mit retardierter wirkstofffreisetzung | |
DE60000286T2 (de) | Lipide enthaltende sojaextrakte, verfahren zu deren herstellung und pharmazeutische und kosmetische zusammensetzung | |
ATE226065T1 (de) | Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung | |
CN108379236A (zh) | 一种非那雄胺缓释片及其制备方法 | |
ATE81586T1 (de) | Arzneiformulierung zur transdermalen absorption des wirkstoffs sowie verfahren zu deren herstellung. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |